Karuna Pharmaceuticals. Developing first in class agents that will improve the lives of those suffering from schizophrenia.
Karuna Pharmaceuticals is a drug development company advancing novel treatments for schizophrenia. Karuna was co-founded by PureTech Ventures together with the world’s leading schizophrenia experts.
Schizophrenia is a devastating illness for both patients and their families. Karuna’s mission is to develop first-in-class agents that will dramatically improve the lives of people living with schizophrenia.
Karuṇā means “the desire to relieve others
of suffering” in Sanskrit.